Functional and Oncological Outcomes of Very Large Prostate Sizes Post Robotic Radical Prostatectomy: A Propensity Score‐Matched Analysis
The Prostate · 2025
DOI: 10.1002/pros.24848 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2025. Verfasst von Ahmed Gamal und 8 weiteren Autor:innen. Beteiligte Einrichtung: AdventHealth Global Robotics Institute, Celebration, Florida, USA. Hauptthemen laut MEDLINE: Prostatectomy, Robotic Surgical Procedures, Prostatic Neoplasms, Prostate. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Robotic‐assisted radical prostatectomy (RARP) is widely used as the main surgical approach to treat prostate cancer in the United States. Prostate size is often described as a factor affecting the outcomes of RARP as shown by many studies. However, these studies are limited to a small number of patients.
Objective
To evaluate the functional and oncologic outcomes of RARP in very large prostate sizes.
Methods
Three hundred and seventy‐five RARP patients were divided into two groups according to prostate size: Group 1 had prostates larger than 150 g and Group 2 smaller than 50 g. Perioperative variables were matched with propensity score matching 1:3 and postoperative variables were analyzed for significant differences in outcomes between groups. Variables analyzed included estimated blood loss (EBL), operative time, catheter time, hospitalization time, postoperative complications, pathological staging, positive surgical margins (PSM) rates, biochemical recurrence (BCR), potency, and continence rates.
Results
The two groups exhibited similar preoperative characteristics. Patients with larger prostates (Group 1) were more likely to have higher blood loss (EBL), longer console time, and more days with catheter. However, we could not find significant difference in the overall postoperative complications (Clavien‐Dindo). Pathological outcomes were also statistically different as patients with larger prostates had (69.7%) more pT2 disease and (12.1%) lower rates of PSM. Finally, we could not find significant difference in the functional outcomes between the groups.
Conclusion
The results demonstrate that prostate size impacts multiple outcomes. Larger prostates had lower‐grade disease, reduced EPE and PSM rates, with no significant differences in BCR or functional outcomes. Perioperative differences, such as increased blood loss and console time, were also observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AdventHealth Global Robotics Institute, Celebration, Florida, USA.
- University of Central Florida (UCF), Orlando, Florida, USA.
- Big and Open Data Innovation Laboratory (BODaI-Lab), University of Brescia, Brescia, Italy.
ORCID-Profile: Ahmed Gamal, Marco Sandri
Zitieren
APA
Gamal, A., Moschovas, M. C., Jaber, A. R., Saikali, S., Reddy, S., Kunta, A., Sandri, M., Rogers, T., & Patel, V. (2025). Functional and Oncological Outcomes of Very Large Prostate Sizes Post Robotic Radical Prostatectomy: A Propensity Score‐Matched Analysis. The Prostate. https://doi.org/10.1002/pros.24848
Vancouver
Gamal A, Moschovas MC, Jaber AR, Saikali S, Reddy S, Kunta A, et al. Functional and Oncological Outcomes of Very Large Prostate Sizes Post Robotic Radical Prostatectomy: A Propensity Score‐Matched Analysis. The Prostate. 2025. doi:10.1002/pros.24848
BibTeX
@article{Gamal2025,
author = {Gamal, Ahmed and Moschovas, Marcio C and Jaber, Abdel R and Saikali, Shady and Reddy, Sumeet and Kunta, Avaneesh and Sandri, Marco and Rogers, Travis and Patel, Vipul},
title = {Functional and Oncological Outcomes of Very Large Prostate Sizes Post Robotic Radical Prostatectomy: A Propensity Score‐Matched Analysis},
journal = {The Prostate},
year = {2025},
doi = {10.1002/pros.24848}
}
EUVIMED